The FDA has always used HbA1c and has not yet agreed to use time in range as the primary endpoint. The advantage of HbA1c is there is decades of experience where people have been able to tie HbA1c ...

As more of my patients use continuous glucose monitors, I find myself relying less on HbA1c and explaining more about time in range. CGMs make it possible to see how much time a patient spends ...

Older adults who spend less time in their designated HbA1c range have higher risks for Alzheimer’s disease and dementias. Time below HbA1c range of 60% or higher increased risk for dementia.

You may be familiar with HbA1c as a metric to determine diabetes management, but there’s a new phrase to familiarise yourself with – Time in Range or TIR- thanks to the advent of continuous glucose ...

Study: Association of Time ... HbA1c and cognitive function have led to inconsistent results. TIR, which reflects the time an individual spends within the 3.9-10.0 mmol/L glucose range, can ...

Underwood, Ph.D., from the William F. Connell School of Nursing at Boston College, and colleagues examined the association between HbA1c time in range (TIR) and the incidence of ADRD in older ...

The primary analysis demonstrated improved outcomes over standard of care in the following domains: Significant reduction in HbA1c: After 13 weeks ... to those using standard of care. Increased time ...

Though their glucose monitors were set to perform readings about nine times a day, the participants started the study with average HbA1C ... 27.6% more time in their ideal glucose ranges compared ...

Underwood, Ph.D., from the William F. Connell School of Nursing at Boston College, and colleagues examined the association between HbA1c time in range (TIR) and the incidence of ADRD in older ...